The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of cancer-specific microbiome signature of response to immune checkpoint inhibitors.
 
Michal Sarfaty
Research Funding - AstraZeneca (Inst)
 
Christopher A. Desjardins
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
 
Paul Giardina
No Relationships to Disclose
 
Kankana Bardhan
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics; Seres Therapeutics
 
Swarna Pandian
Employment - Abpro; Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
Research Funding - Abpro; Seres Therapeutics
 
Keith Halley
Employment - Seres Therapeutics
 
Elizabeth M. Halvorsen
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
 
Margaret K. Callahan
Employment - Bristol-Myers Squibb (I); Bristol-Myers Squibb (I); Celgene (I); Kleo Pharmaceuticals (I)
Consulting or Advisory Role - AstraZeneca; Immunocore; Merck; Moderna Therapeutics
Research Funding - Bristol-Myers Squibb (Inst)
Other Relationship - Clinical Care Options; Potomac Center for Medical Education
 
Michael A. Postow
Honoraria - Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Eisai; Incyte; Merck; Newlink Genetics; Novartis; Pfizer
Research Funding - Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Infinity Pharmaceuticals (Inst); Merck (Inst); Novartis (Inst); Rgenix (Inst)
 
Chung-Han Lee
Honoraria - Intellisphere
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Exelixis; Merck; Pfizer/EMD Serono
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Eisai (Inst); Exelixis (Inst); Lilly (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Calithera Biosciences; Eisai
 
Ritesh Kotecha
Research Funding - Pfizer (Inst); Takeda (Inst)
 
Daniel Kashani
No Relationships to Disclose
 
Neha Ratna
No Relationships to Disclose
 
Ashley Marie Regazzi
No Relationships to Disclose
 
Matthew R. Henn
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
 
Matthew D. Hellmann
Stock and Other Ownership Interests - Arcus Biosciences; Immunai; Shattuck Labs; Shattuck Labs
Consulting or Advisory Role - Achilles Therapeutics; Arcus Biosciences; AstraZeneca/MedImmune; Blueprint Medicines; Bristol-Myers Squibb; Genentech; Immunai; Merck; Mirati Therapeutics; Natera; Nektar; Shattuck Labs; Syndax
Research Funding - Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - A patent has been filed by Memorial Sloan Kettering (PCT/US2015/062208) for the use of tumor mutation burden for prediction of immunotherapy efficacy, and which is licensed to Personal Genome Diagnostics. (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Lilly
 
Gopa Iyer
Consulting or Advisory Role - Basilea; Bayer; Janssen; Mirati Therapeutics
Research Funding - Bayer (Inst); Debiopharm Group (Inst); Mirati Therapeutics (Inst); Novartis (Inst)
 
Christopher B. Ford
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
 
Jonathan U. Peled
Consulting or Advisory Role - Da Volterra; MaaT Pharma
Research Funding - Seres Therapeutics
Patents, Royalties, Other Intellectual Property - IP licensing fees, Seres Therapeutics
Travel, Accommodations, Expenses - Hanson Wade